Nishimura J K, Hodge D O, Bourne W M
Department of Ophthalmology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA.
Ophthalmology. 1999 Oct;106(10):1962-5. doi: 10.1016/S0161-6420(99)90409-8.
To determine when corneal transplants develop the decreased endothelial cell density that predisposes to late endothelial failure (LEF).
Noted cohort study within a prospective case series.
The authors compared 21 grafts that developed LEF with the remaining transplants (controls) in a longitudinal cohort study of 500 consecutive penetrating keratoplasties by 1 surgeon. Eyes regrafted during the study, fellow eyes of bilateral cases, and patients who did not want their data used for research purposes were excluded, leaving 389 grafts in 389 patients for analysis.
Penetrating keratoplasty.
Endothelial cell density before surgery and at 2 months and 1, 3, 5, and 10 years after surgery.
Grafts with LEF had lower median endothelial cell densities than other grafts, both before surgery (2710 cells/mm2 vs. 2991 cells/mm2; P = 0.02) and 2 months after surgery (1895 cells/mm2 vs. 2501 cells/mm2; P < 0.001), a difference that was maintained through 5 postoperative years. Despite having lower preoperative cell densities, the grafts with LEF had larger median endothelial cell losses 2 months after keratoplasty (31% vs. 16%, P = 0.002). The endothelial cell loss subsequent to the 2-month examination, however, was not increased in the grafts with LEF. Risk factors for developing LEF included a low endothelial cell density before surgery (P = 0.007) and 2 months after surgery (P = 0.002), aphakia or pseudophakia (P = 0.04), older recipient age (P = 0.002) and older donor age (P = 0.03), and occurrence of an endothelial rejection episode (P = 0.03).
Corneal grafts with LEF, the major cause of graft failure after 5 postoperative years, fail from low initial endothelial cell density rather than an increased rate of chronic postoperative cell loss. Improved techniques of corneal preservation should decrease the rate of LEF. In addition to low preoperative and 2-month postoperative endothelial cell density, a higher risk of LEF is also seen in patients with aphakia or pseudophakia, older recipient age, older donor age, and occurrence of an endothelial rejection episode.
确定角膜移植何时会出现内皮细胞密度降低,从而易引发晚期内皮功能衰竭(LEF)。
前瞻性病例系列中的队列研究。
在一项由1名外科医生进行的500例连续穿透性角膜移植术的纵向队列研究中,作者将21例发生LEF的移植物与其余移植物(对照组)进行了比较。研究期间再次移植的眼、双侧病例的对侧眼以及不希望其数据用于研究目的的患者被排除,最终纳入389例患者的389个移植物进行分析。
穿透性角膜移植术。
术前、术后2个月以及术后1、3、5和10年时的内皮细胞密度。
发生LEF的移植物,无论是术前(2710个细胞/mm² 对2991个细胞/mm²;P = 0.02)还是术后2个月(1895个细胞/mm² 对2501个细胞/mm²;P < 0.001),其内皮细胞密度中位数均低于其他移植物,这种差异在术后5年内一直存在。尽管术前细胞密度较低,但发生LEF的移植物在角膜移植术后2个月时内皮细胞损失中位数更大(31% 对16%,P = 0.002)。然而,在2个月检查后,发生LEF的移植物的内皮细胞损失并未增加。发生LEF的危险因素包括术前(P = 0.007)和术后2个月(P = 0.002)内皮细胞密度低、无晶状体或人工晶状体眼(P = 0.04)、受者年龄较大(P = 0.002)和供者年龄较大(P = 0.03)以及发生内皮排斥反应(P = 0.03)。
LEF是术后5年移植物失败的主要原因,角膜移植物因初始内皮细胞密度低而非术后慢性细胞损失率增加而失败。改进角膜保存技术应能降低LEF的发生率。除术前和术后2个月内皮细胞密度低外,无晶状体或人工晶状体眼、受者年龄较大、供者年龄较大以及发生内皮排斥反应的患者发生LEF的风险也更高。